Crinetics Pharmaceuticals (CRNX) Q3 2025 Earnings

7AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-1.23
-1.11
-1
-0.88

Details

Expected EPS
-1.0815
Actual EPS
-1.23
Surprise EPS
-0.15
Surprise Percent
+13.73%

Description

Crinetics Pharmaceuticals (CRNX) has reported earnings of -1.23 per share for Q3 2025.

0 Comments

Share your thoughts